CT 01 - Clinical Trials Session

Moderator(s)

• 

  Kenneth Rosenzweig, MD, FASTRO

  Icahn School of Medicine at Mount Sinai
  New York, New York, United States
• 

  Farzan Siddiqui, MD, PhD

  Henry Ford Health/Henry Ford Hospital
  Detroit, MI

Presentations:

• 1:00 PM – 1:10 PM ET

  A Prospective, Phase II Study of ¹⁷⁷Lu-Dotatate in Patients with Surgery- and Radiation-Refractory Meningioma: Results of the WHO Grade II/III Cohort
  

  Presenter: Kenneth Merrell, MD, MS – Mayo Clinic Alix School of Medicine
• 1:10 PM – 1:20 PM ET

  A Phase 3 Study of Pembrolizumab (Pembro) + Concurrent Chemoradiotherapy (CCRT) for High-Risk Locally Advanced Cervical Cancer (LACC): Safety Findings
  

  Presenter: Gabriella Macchia, MD – Responsible Research Hospital
• 1:20 PM – 1:30 PM ET

  Hypofractionated Whole-Breast Irradiation with Simultaneous Integrated Boost for Breast Cancer: Primary Analysis of the HYPOSIB-Trial (ARO 2013-05)
  

  Presenter: David Krug, MD – University Hospital Hamburg-Eppendorf
• 1:30 PM – 1:40 PM ET

  Discussant
  

  Discussant: Kimberly Corbin, MD – Mayo Clinic Alix School of Medicine
• 1:40 PM – 1:50 PM ET

  Pirfenidone in the Treatment of Radiation-Induced Lung Injury: A Randomized, Controlled, Multicenter Clinical Trial
  

  Presenter: Ming Chen, MD – Sun Yat-Sen University Cancer Center
• 1:50 PM – 2:00 PM ET

  Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicenter Randomized Controlled Trial
  

  Presenter: Vedang Murthy, MD – Tata Memorial Centre
• 2:00 PM – 2:10 PM ET

  MR-Linac On-Line Weekly Adaptive Radiotherapy for High Grade Glioma (HGG): Results from the UNITED Single Arm Phase II Trial
  

  Presenter: Jay Detsky, MD, PhD – Sunnybrook Health Sciences Centre
• 2:10 PM – 2:20 PM ET

  Short-Term Androgen Deprivation Therapy and High-Dose Radiotherapy in Intermediate- and High-Risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase III Trial
  

  Presenter: Nicolas Demogeot, MD – Institut de Cancerologie de Lorraine
• 2:20 PM – 2:30 PM ET

  A Multicenter Phase III Randomized Clinical Trial Comparing the Efficacy of an Adjuvant SOX Chemotherapy Regimen with SOX Combined with a Simultaneous Radiotherapy Regimen after D2 Radical Resection f
  

  Presenter: Ou-ying Yan, MD – Cancer Center, West China Hospital, Sichuan University